Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Juvederm Collection
02 1Synvisc
03 5Synvisc/Synvisc One
04 1Synvisc/Synvisc-One
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2019 Revenue in Millions : 337
2018 Revenue in Millions : 341
Growth (%) : -1
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 232
2019 Revenue in Millions : 374
Growth (%) : -38
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Bone Health
Currency : USD
2014 Revenue in Millions : -5.10%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Bone Health
Currency : USD
2015 Revenue in Millions : 387
2014 Revenue in Millions : 454
Growth (%) : 17%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Bone Health
Currency : USD
2016 Revenue in Millions : 432
2015 Revenue in Millions : 438
Growth (%) : -1
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Bone and Joint Diseases
Currency : USD
2017 Revenue in Millions : 480
2016 Revenue in Millions : 506
Growth (%) : -5
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Bone And Joint Diseases
Currency : USD
2018 Revenue in Millions : 354
2017 Revenue in Millions : 437
Growth (%) : -19%
Main Therapeutic Indication : Dermatology
Currency : USD
2020 Revenue in Millions : 718
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Dermatology
Currency : USD
2021 Revenue in Millions : 1,535
2020 Revenue in Millions : 718
Growth (%) : 114
Main Therapeutic Indication : Dermatology
Currency : USD
2022 Revenue in Millions : 1,428
2021 Revenue in Millions : 1,535
Growth (%) : -7
